FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Coumadin Tablets
Status: Discontinuation
»Therapeutic Categories: Hematology

Expand all

Bristol Myers Squibb Co. (New 04/24/2020)

Company Contact Information:
800-332-2056

Presentation Posting Date Related Information
1 mg (NDC 0056-0169-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
1 mg (NDC 0056-0169-75) 04/24/2020 Projection Cease of Commercialization: 1Q 2020
2 mg (NDC 056-0170-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
2 mg (NDC 0056-0170-75) 04/24/2020 Projection Cease of Commercialization: 1Q 2020
2 1/2 mg (NDC 0056-0176-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
2 1/2 mg (NDC 0056-0176-75) 04/24/2020 Projection Cease of Commercialization: 1Q 2020
3 mg (NDC 0056-0188-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
3 mg (NDC 0056-0188-75) 04/24/2020 Projection Cease of Commercialization: 1Q 2020
4 mg (NDC 0056-0168-70) 04/24/2020 Projection Cease of Commercialization: 1Q 2020
4 mg (NDC 0056-0168-75) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
5 mg (NDC 0056-0172-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
5 mg (NDC 0056-0172-75) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
6 mg (NDC 0056-0189-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
6 mg (NDC 0056-0189-75) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
7 1/2 mg (NDC 0056-0173-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
7 1/2 mg (NDC 0056-0173-75) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
10 mg (NDC 0056-0174-70) 04/24/2020 Projection Cease of Commercialization: 2Q 2020
10 mg (NDC 0056-0174-75) 04/24/2020 Projection Cease of Commercialization: 2Q 2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English